[Mechanism of p38 mitogen-activated protein kinase inhibitor SB203580 to glucocorticoid sensitivity]

Wen Li1, Jiang-tao Lin, Li-chao Sun

  • 1Chinese Academy of Medical Sciences, Beijing, China.

Zhonghua Yi Xue Za Zhi
|November 20, 2012
PubMed
Abstract

Insights

This study demonstrates that SB203580 enhances corticosteroid sensitivity in asthma models by improving glucocorticoid receptor (GR) nuclear translocation. This finding offers a potential therapeutic mechanism for glucocorticoid resistance in asthma.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Pharmacology

Background:

  • Asthma is a chronic respiratory disease often associated with inflammation and airway hyperresponsiveness.
  • Glucocorticoid resistance is a significant clinical challenge in managing severe asthma.
  • Cigarette smoke exposure can exacerbate asthma symptoms and contribute to glucocorticoid resistance.

Purpose of the Study:

  • To develop a rat model of asthma induced by cigarette smoke exposure.
  • To investigate nicotine-induced glucocorticoid resistance in A549 alveolar epithelial cells.
  • To elucidate the mechanism by which the p38 MAPK inhibitor SB203580 affects glucocorticoid sensitivity.

Main Methods:

  • Establishment of a rat model involving asthma and cigarette smoke exposure.
  • In vivo analysis of glucocorticoid receptor (GR), HSP90, and p38 MAPK mRNA and protein expression using RT-PCR and Western blot.
  • In vitro study using A549 cells treated with dexamethasone, nicotine, and SB203580.
  • Immunofluorescence staining to assess GR nuclear translocation in A549 cells.

Main Results:

  • Cigarette smoke exposure significantly altered the expression of GR, HSP90, and p38 MAPK in asthmatic rats.
  • Nicotine treatment in A549 cells induced glucocorticoid resistance.
  • SB203580 treatment significantly increased the nuclear translocation of GR in A549 cells compared to nicotine-treated cells.
  • SB203580 treatment reversed nicotine-induced changes in HSP90 and p38 MAPK expression.

Conclusions:

  • The p38 MAPK pathway plays a crucial role in mediating glucocorticoid resistance in asthma.
  • SB203580 enhances corticosteroid sensitivity by promoting the nuclear translocation of the glucocorticoid receptor (GR).
  • Targeting the p38 MAPK pathway may represent a novel therapeutic strategy for overcoming glucocorticoid resistance in asthma.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...